Prevalence of the endolymphatic sac hypoplasia in a cohort of individuals without Meniere disease
Metadatos
Mostrar el registro completo del ítemAutor
Robles Bolívar, Paula; Martínez Martínez, Marta; Martín-Márquez, Rocío; Berrio-Domínguez, Inés; Martín Rodríguez, José Luis; Lopez-Escamez, Jose AntonioEditorial
Sage
Materia
Diseases Meniere Endolymphatic sac
Fecha
2025-08-25Referencia bibliográfica
Robles-Bolivar P, Martínez-Martínez M, Martín-Márquez R, Berrio-Domínguez I, Martin-Rodríguez JL, Lopez-Escamez JA. Prevalence of the endolymphatic sac hypoplasia in a cohort of individuals without Meniere disease. Journal of Vestibular Research. 2025;0(0). doi: 10.1177/09574271251371541
Patrocinador
The University of Sydney (K7013_B3413 Grant)Resumen
Purpose: To estimate the prevalence of endolymphatic sac hypoplasia (EShp)—a proposed specific finding in Menière ´ ’s
disease (MD) that defines an endophenotype characterized by bilateral involvement, male predominance, temporal bone
abnormalities, and familial clustering—in individuals without MD, to assess its specificity for the condition.
Methods: We analyzed 956 temporal bone CT scans from individuals without MD to assess the prevalence of EShp using
the Angular Trajectory of the Vestibular Aqueduct (ATVA) marker. ATVA distribution, reproducibility, and associations
with clinical variables were also evaluated.
Results: EShp was identified in 6 ears from 4 individuals, yielding a prevalence of 0.6% per patient and 0.8% per ear. ATVA
values had a median of 95.0° (IQR = 12.5°, range 65.9°–159.4°). Interobserver agreement was good (ICC = 0.75), with a
mean bias of 6.2° ± 5.4° and 5.5% of ears outside the 95% limits of agreement. No significant associations were found
between ATVA and sex, age, or clinical diagnosis.
Conclusions: EShp is rare in individuals without MD, supporting its specificity and potential role in MD pathophysiology.
The ATVA marker is reliable and reproducible and may serve as a CT biomarker for the hypoplastic MD endophenotype.





